Lyme Disease H2 2019 Pipeline Review, with Focus on Key Players such as Inovio Pharmaceuticals and Valneva SE
- Wednesday, October 9, 2019, 7:13
- PR Newswire
- Add a comment
DUBLIN, Oct. 9, 2019 /PRNewswire/ — The “Lyme Disease – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The Lyme Disease – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Lyme Disease…
About the Author
admin has written 20655 stories on this site.